A lawsuit filed by 35 states and the District of Columbia alleges that drugmaker Indivior violated antitrust laws by trying to extend its monopoly over Suboxone, New York's attorney general announced Thursday. Suboxone is a prescription drug used to treat patients addicted to heroin, painkillers and other opioid drugs.
The company's actions drove up prices, depriving consumers and the states of lower costs, according to California's attorney general.
The states want Indivior to pay back the billions of dollars in profits earned as a result of its alleged practices.
The company and MonoSol Rx conspired to block generic competitors for Suboxone by switching the drug from a tablet to a dissolving film, the lawsuit claims. As a result, consumers have been paying artificially high prices for Suboxone since 2009, when a generic alternative might otherwise have become available.
more: http://www.cnn.com/2016/09/23/health/suboxone-lawsuit-antitrust/
The company's actions drove up prices, depriving consumers and the states of lower costs, according to California's attorney general.
The states want Indivior to pay back the billions of dollars in profits earned as a result of its alleged practices.
The company and MonoSol Rx conspired to block generic competitors for Suboxone by switching the drug from a tablet to a dissolving film, the lawsuit claims. As a result, consumers have been paying artificially high prices for Suboxone since 2009, when a generic alternative might otherwise have become available.
more: http://www.cnn.com/2016/09/23/health/suboxone-lawsuit-antitrust/